| Atkinson Eye Care, P.c. | |
|
2100 N. Huntington Drive, Unit A, Algonquin, IL 60102-5940 | |
| (847) 854-5700 | |
| (847) 854-5762 |
| Full Name | Atkinson Eye Care, P.c. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2100 N. Huntington Drive, Unit A, Algonquin, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043330418 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | William R Atkinson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396752671 PECOS PAC ID: 1456244714 Enrollment ID: I20040204000907 |
News Archive
In a recent study by US researchers (currently available on the medRxiv* preprint server), a specific immunoassay based on the spike glycoprotein's receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not only well suited for the detection of antibody response after infection and vaccination but may also represent a method of choice when conducting seroepidemiological studies.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it will release the BUDDY Tablet Caddy two-minute commercial and the one-page landing page after the close of trading on November 20, 2009 for the American Music Awards weekend.
UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.
New details emerge about the cut to the health law's Prevention and Public Health Fund in the $1 trillion spending bill, but a jobless benefits extension in Congress stalls. In the meantime, a mental health plan pushed by President Obama will get spending bill funds.
› Verified 1 days ago
| Provider Name | Elizabeth A Mihevc |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1093722373 PECOS PAC ID: 8921150269 Enrollment ID: I20090716000486 |
News Archive
In a recent study by US researchers (currently available on the medRxiv* preprint server), a specific immunoassay based on the spike glycoprotein's receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not only well suited for the detection of antibody response after infection and vaccination but may also represent a method of choice when conducting seroepidemiological studies.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it will release the BUDDY Tablet Caddy two-minute commercial and the one-page landing page after the close of trading on November 20, 2009 for the American Music Awards weekend.
UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.
New details emerge about the cut to the health law's Prevention and Public Health Fund in the $1 trillion spending bill, but a jobless benefits extension in Congress stalls. In the meantime, a mental health plan pushed by President Obama will get spending bill funds.
› Verified 1 days ago
| Provider Name | Jay B Patel |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1467947770 PECOS PAC ID: 3870823529 Enrollment ID: I20190924001578 |
News Archive
In a recent study by US researchers (currently available on the medRxiv* preprint server), a specific immunoassay based on the spike glycoprotein's receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not only well suited for the detection of antibody response after infection and vaccination but may also represent a method of choice when conducting seroepidemiological studies.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it will release the BUDDY Tablet Caddy two-minute commercial and the one-page landing page after the close of trading on November 20, 2009 for the American Music Awards weekend.
UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.
New details emerge about the cut to the health law's Prevention and Public Health Fund in the $1 trillion spending bill, but a jobless benefits extension in Congress stalls. In the meantime, a mental health plan pushed by President Obama will get spending bill funds.
› Verified 1 days ago
| Provider Name | Tea Dimo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1306613518 PECOS PAC ID: 6204271463 Enrollment ID: I20240227002891 |
News Archive
In a recent study by US researchers (currently available on the medRxiv* preprint server), a specific immunoassay based on the spike glycoprotein's receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not only well suited for the detection of antibody response after infection and vaccination but may also represent a method of choice when conducting seroepidemiological studies.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it will release the BUDDY Tablet Caddy two-minute commercial and the one-page landing page after the close of trading on November 20, 2009 for the American Music Awards weekend.
UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.
New details emerge about the cut to the health law's Prevention and Public Health Fund in the $1 trillion spending bill, but a jobless benefits extension in Congress stalls. In the meantime, a mental health plan pushed by President Obama will get spending bill funds.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Atkinson Eye Care, P.c. 2100 N. Huntington Drive, Unit A, Algonquin, IL 60102-5940 Ph: (847) 854-5700 | Atkinson Eye Care, P.c. 2100 N. Huntington Drive, Unit A, Algonquin, IL 60102-5940 Ph: (847) 854-5700 |
News Archive
In a recent study by US researchers (currently available on the medRxiv* preprint server), a specific immunoassay based on the spike glycoprotein's receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not only well suited for the detection of antibody response after infection and vaccination but may also represent a method of choice when conducting seroepidemiological studies.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it will release the BUDDY Tablet Caddy two-minute commercial and the one-page landing page after the close of trading on November 20, 2009 for the American Music Awards weekend.
UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.
New details emerge about the cut to the health law's Prevention and Public Health Fund in the $1 trillion spending bill, but a jobless benefits extension in Congress stalls. In the meantime, a mental health plan pushed by President Obama will get spending bill funds.
› Verified 1 days ago
Dawn Wickizer Optometrist Medicare: Medicare Enrolled Practice Location: 436 S Randall Rd, Algonquin, IL 60102 Phone: 847-658-4242 Fax: 847-658-5643 | |
Wendy Jean Mchugh, OD Optometrist Medicare: Medicare Enrolled Practice Location: 245 Stonegate Rd, Algonquin, IL 60102 Phone: 847-658-0120 Fax: 847-658-0610 | |
Morfoot Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 400 S Randall Rd, Algonquin, IL 60102 Phone: 847-854-5412 | |
In Focus Eyecare P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 750 S Randall Rd, Algonquin, IL 60102 Phone: 847-458-5343 Fax: 847-458-5344 | |
Precision Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 204 S Main St, Algonquin, IL 60102 Phone: 224-678-9043 | |
Amna Mirza Malik, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 750 S Randall Rd, Algonquin, IL 60102 Phone: 847-458-5343 Fax: 847-458-4344 |